Blood test breakthrough: AI reads platelets to spot lung cancer
NCT ID NCT07460440
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to see if a new blood test can accurately detect lung cancer by analyzing RNA from platelets. Researchers will collect blood samples from 240 adults with lung cancer or suspicious lung nodules. The goal is to validate whether this AI-powered test can distinguish between benign and malignant nodules, potentially offering a non-invasive screening tool.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Utah
Salt Lake City, Utah, 84112, United States
-
Veterans Affairs SLC Health Care System (VAMC)
Salt Lake City, Utah, 84148-0001, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Your Tumor's DNA might predict immunotherapy success
- Which lung biopsy method is safer and more accurate?
- Can a new PET tracer light up hidden cancers?